The genetic algorithm for breast tumor diagnosis-The case of DNA viruses

Applied Soft Computing Journal

Volumn 9, Issue 2, 2009, Pages 703-710

  Tseng, Ming Hseng ^a   Liao, Hung Chang ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Breast tumor; DNA viruses; Genetic algorithm (GA)

Indexed keywords

ALGORITHMS; ANALYSIS OF VARIANCE (ANOVA); BIOINFORMATICS; DNA; GENES; GENETIC ALGORITHMS; INFORMATION MANAGEMENT; INFORMATION THEORY; MICROORGANISMS; NUCLEIC ACIDS; ONCOLOGY; ORGANIC ACIDS; REGRESSION ANALYSIS; TUMORS;

BREAST CANCERS; BREAST TUMOR; DNA VIRUSES; GENETIC ALGORITHM (GA); HERPES SIMPLEX VIRUS (HSV); INFORMATION MEASUREMENT; SIGNIFICANT FACTOR;

VIRUSES;

EID: 58549093730     PISSN: 15684946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.asoc.2008.09.013     Document Type: Article

References (59)

1. Cancer Registry Annual Report (1995), Department of Health, Executive Yuan (Taipei), Taiwan, 1995.
2. Overview of Public Health, Department of Health, Executive Yuan (Taipei), Taiwan, 1998.
3. Cancer Registry Annual Report, Executive Yuan (Taipei), Taiwan, 2004.
4. Cheng S.H., Tsou M.H., Liu M.C., and Jian J.J. Unique features of breast cancer in Taiwan. Breast Cancer Res. Treat. 63 3 (2000) 213-220
5. Ziegler R.G., Hoover R.N., Pike M.C., Hildesheim A., Nomura A.M., West D.W., Wu-Williams A.H., Kolonel L.N., Horn-Ross P.L., Rosenthal J.F., and Hyer M.B. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer. Inst. 85 (1993) 1819-1827
6. Yu H., Rohan T.E., Cook M.G., Howe G.R., and Miller A.B. Risk factors for fibroadenoma: a case-control study in Australia. Am. J. Epidemiol. 135 3 (1992) 247-259
7. N.J. Dimmock, S.B. Primrose, Carcinogenesis and tumor viruses: introduction to modern virology, 4th ed., Blackwell Science Ltd., London, pp. 256-275.
8. Wu A., Mazumder A., Martuza R.L., Liu X., Thein M., Meehan K.R., and Rabkin S.D. Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation. Cancer Res. 61 7 (2001) 3009-3015
9. Hu J., Hallden G., Shorrock C., Simpson G., Coffin R., Kamalati T., and Coombes R. Combination of a second generation genetically modified herpes simplex virus type 1 (HSV-1) with paclitaxel in the treatment of breast cancer in vitro. Mol. Ther. 9 (2004) S105
10. Teshigahara O., Goshima F., Takao K., Kohno S., Kimata H., Nakao A., and Nishiyama Y. Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10. J. Surg. Oncol. 85 1 (2004) 42-47
11. Wang S., and Vos J.-M. A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer to human cells in vitro and in vivo. J. Virol. 70 12 (1996) 8422-8430
12. Liu H., Xu Z.-L., Wang Y., Yang L., Feng O., Li Y., Wang Y.-M., and Xhang G.-G. Production of anti-tumor human monoclonal antibodies using different approaches. Hum. Antibodies 4 1 (1993) 2-8
13. Katano M., Kubota E., Nagumo F., Matsuo T., Hisatsugu T., and Tadano J. Inhibition of tumor cell growth by a human B-cell line. Biotherapy 8 1 (1995) 1-6
14. Yip Y.L., Hawkins N.J., Clark M.A., and Ward R.L. Evaluation of different lymphoid tissue sources for the construction of human immunoglobulin gene libraries. Immunotechnology 3 3 (1997) 195-203
15. Fina F., Romain S., Ouafik L.H., Palmari J., Ayed F.B., Benharkat S., Bonnier P., Spyratos F., Foekens J.A., Rose C., Buisson M., Gerard H., Reymond M.O., Seigneurin J.M., and Martin P.M. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br. J. Cancer 84 6 (2001) 783-790
16. Grinstein S., Preciado M.V., Gattuso P., Chabay P.A., Warren W.H., De Matteo E., and Gould V.E. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res. 62 17 (2002) 4876-4878
17. Xue S.A., Lampert I.A., Haldane J.S., Bridger J.E., and Griffin B.E. Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger?. Br J. Cancer 89 1 (2003) 113-119
18. Huang J., Chen H., Hutt-Fletcher L., Ambinder R.F., and Hayward S.D. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J. Virol. 77 24 (2003) 13267-13274
19. Ribeiro-Silva A., Ramalho L.N.Z., Garcia S.B., and Zucoloto S. Does the correlation between EBN-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein-Barr virus-related breast malignancies?. Braz. J. Med. Biol. Res. 37 1 (2004) 89-95
20. Baeyens A., Thierens H., Claes K., Poppe B., de Ridder L., and Vral A. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers. Int. J. Radiat. Biol. 80 10 (2004) 745-756
21. Strender L.-E., Blomgren H., Petrini B., Wasserman J., Forsgren M., Norberg R., Baral E., and Wallgren A. Immunologic monitoring in breast cancer patients receiving postoperative adjuvant chemotherapy. Cancer 48 9 (1981) 1996-2002
22. Lee S.W., Reimer C.L., Oh P., Campbell D.B., and Schnitzer J.E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16 11 (1998) 1391-1397
23. Still I.H., Hamilton M., Vince P., Wolfman A., and Cowell J.K. Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon. Oncogene 18 27 (1999) 4032-4038
24. Svane I.M., Nikolajsen K., Hansen S.W., Kamby C., Nielsen D.L., and Johnsen H.E. Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method. Bone Marrow Transplant. 29 8 (2002) 659-666
25. Akbulut H., Zhang L., Tang Y., and Deisseroth A. Cytotoxic effect of replication-competent adenoviral vectors carrying l-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Cancer Gene Ther. 10 5 (2003) 388-395
26. Ma N., Szmitko P., Brade A., Chu I., Lo A., Woodgett J., Henry Klamut J., and Liu F.-F. Kinase-dead PKB gene therapy combined with hyperthermia for human breast cancer. Cancer Gene Ther. 11 1 (2004) 52-60
27. Zhu Z.B., Makhija S.K., Lu B., Wang M., Kaliberova L., Liu B., Rivera A.A., Nettelbeck D.M., Mahasreshti P.J., Leath C.A., Yamaoto M., Alvarez R.D., and Curiel D.T. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter. Gene Ther. 11 7 (2004) 645-648
28. La Vecchia C., Tavani A., Franceschi S., and Parazzini F. Oral contraceptives and cancer. A review of the evidence. Drug Saf. 14 4 (1996) 260-272
29. Chang J.-G., Su T.-H., Wei H.-J., Wang J.-C., Chen Y.-J., Chang C.-P., and Jeng C.-J. Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers. Br. J. Cancer 79 3-4 (1999) 445-450
30. Liu Y., Klimberg V.S., Andrews N.R., Hicks C.R., Peng H., Chiriva-Internati M., Henry-Tillman R., and Hermonat P.L. Human papillomavirus DNA is present in a subset of unselected breast cancers. J. Hum. Virol. 4 6 (2001) 329-334
31. Widschwendter A., Brunhuber T., Wiedemair A., Mueller-Holzner E., and Marth C. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J. Clin. Virol. 31 4 (2004) 292-297
32. Allan A.E., Shoji T., Li N., Buralge A., Davis B., and Bhawan J. Two cases of Kaposi's sarcoma mimicking Stewart-Treves syndrome found to be human herpesvirus-8. Am. J. Dermatopathol. 23 5 (2001) 431-436
33. Newton R., Ziegler J., Bourboulia D., Casabonne D., Beral V., Mbidde E., Carpenter L., Reeves G., Parkin D.M., Wabinga H., Mbulaiteye S., Jaffe H., Weiss R., and Boshoff C. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. Int. J. Cancer 103 (2003) 226-232
34. Klein G., and Klein E. Surveillance against tumors-is it mainly immunological?. Immunol. Lett. 100 1 (2005) 29-33
35. Andres A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit. Rev. Oncol. Hematol. 56 1 (2005) 71-85
36. Stilous S., Bamidis P.D., Maglaveras N., and Pappas C. Mining association rules from clinical database: an intelligent diagnosis process in healthcare. Proceedings of the Annual Meeting of the American Medical Informatics Association (2001) 1399-1403
37. Pendharkar P.C., Rodger J.A., Yaverbaum G.T., Herman N., and Benner M. Association, statistical, mathematical and neural approaches for mining breast cancer patterns. Expert Syst. Appl. 17 (1999) 223-232
38. Wang X.H., Zheng B., Good W.F., King J.L., and Chang Y.H. Computer-assisted diagnosis of breast cancer using a data-driven Bayesian belief network. Int. J. Med. Inform. 54 (1999) 115-126
39. Leu S.S., Chen A.T., and Yang C.H. A GA-based fuzzy optimal model for construction time-cost trade-off. Int. J. Proj. Manage. 19 (2001) 47-58
40. Wang Y.Z. A GA-based methodology to determine an optimal curriculum for schools. Expert Syst. Appl. 28 1 (2005) 163-174
41. Shin K.S., and Lee Y.J. A genetic algorithm applications in bankruptcy prediction modeling. Expert Syst. Appl. 23 3 (2002) 321-328
42. Kim M.J., and Han I. The discovery of experts' decision rules from qualitative bankruptcy data using genetic algorithms. Expert Syst. Appl. 25 4 (2003) 637-646
43. Holland J.H. Adaptation in Natural and Artificial Systems (1975), The University of Michigan Press, Ann Arbor
44. Goldberg D.E. Genetic Algorithm in Search, Optimisation, and Machine Learning (1989), Addison-Wesley, Boston
45. Coley D.A. An Introduction to Genetic Algorithms for Scientists and Engineers (1998), World Scientific, London
46. Davis L. Handbook of Genetic Algorithms (1991), Van Norstrand Reinhold, New York
47. Goldberg D.E., and Richardson J. Genetic algorithms with sharing for multimodal function optimisation. Proceedings of the 2nd International Conference on Genetic Algorithms on Genetic Algorithms and their Application. Cambridge, Massachusetts, USA (1987) 41-49
48. Yuan Y., and Zhuang H. A genetic algorithm for generating fuzzy classification rules. Fuzzy Sets Syst. 84 (1996) 1-19
49. Tsai J.-H., Tsai C.-H., Chang M.-H., Lin S.-J., Xu F.-L., and Yang C.-C. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J. Med. Virol. 75 (2005) 276-281
50. Band V., Zajchowski D., Kulesa V., and Sager R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc. Natl. Acad. Sci. U. S. A. 87 1 (1990) 463-467
51. Mitchel T.M. Machine Learning (1997), McGraw-Hill, New York
52. Labrecque L.G., Barnes D.M., Fentiman I.S., and Grifin B.E. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 55 1 (1995) 39-45
53. Chu J.-S., Chen C.-C., and Chang K.-J. In situ detection of Epstein-Barr virus in breast cancer. Cancer Lett. 124 1 (1998) 53-57
54. Glaser S.L., Ambinder R.F., DiGiuseppe J.A., Horn-Ross P.L., and Hsu J.L. Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int. J. Cancer 75 4 (1998) 555-558
55. Bonnet M., Guinebretiere J.-M., Kremmer E., Grunewald V., Benhamou E., Contesso G., and Joab I. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 91 16 (1999) 1376-1381
56. McCall S.A., Lichy J.H., Bijwaard K.E., Aguilers N.S., Chu W.-S., and Taubenberger J.K. Epstein-Barr virus detection in ductal carcinoma of the breast. J. Natl. Cancer Inst. 93 2 (2001) 148-150
57. Murray P.G., Lissauer D., Junying J., Davies G., Moore S., Bell A., Timms J., Rowlands D., McConkey C., Reynolds G.M., Ghataura S., England D., Caroll R., and Young L.S. Reactivity with a monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of EBV genome. Cancer Res. 63 9 (2003) 2338-2343
58. Richardson A.K., Cox B., McCredie M.R.E., Dite G.S., Chang J.-H., Gertig D.M., Southey M.C., Giles G.G., and Hopper J.L. Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study. Br. J. Cancer 90 11 (2004) 2149-2152
59. Richardson A. Is breast cancer caused by late exposure to a common virus?. Med. Hypotheses 48 (1997) 491-497